Aratana Therapeutics Inc (NASDAQ:PETX)

14.17
Delayed Data
As of Jul 02
 -0.21 / -1.46%
Today’s Change
9.20
Today|||52-Week Range
20.63
-20.48%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$494.7M

Company Description

Aratana Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the licensing, development and commercialization of innovative prescription medications for pets, or pet therapeutics. It delivers innovative prescription medicines that address significant medical needs for cats and dogs (companion animals). The company licenses proprietary, patent-protected compounds from human pharmaceutical and biotechnology companies. Aratana Therapeutics was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Kansas City, KS.

Contact Information

Aratana Therapeutics, Inc.
1901 Olathe Boulevard
Kansas City Kansas 66103
P:(913) 951-2132
Investor Relations:
(913) 353-1023

Employees

Shareholders

Other institutional39.38%
Mutual fund holders37.78%
Individual stakeholders26.52%

Top Executives

Steven St. PeterPresident, Chief Executive Officer & Director
Craig A. ToomanCFO, Treasurer & Head-Investor Relations
Linda RhodesChief Scientific Officer
Ernst HeinenChief Development Officer
Julia A. StephanusChief Commercial Officer

To view my watchlist

Not a member yet?

Sign up now for a free account